These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4282384)

  • 41. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.
    Creese I; Iversen SD
    Brain Res; 1973 Jun; 55(2):369-82. PubMed ID: 4145950
    [No Abstract]   [Full Text] [Related]  

  • 42. Different central mediation of the stimulant effects of amphetamine and its p-chloro analogue.
    Frey HH; Magnussen MP
    Biochem Pharmacol; 1968 Jul; 17(7):1299-307. PubMed ID: 5659777
    [No Abstract]   [Full Text] [Related]  

  • 43. Rotational behavior induced by cocaine analogs in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra: dependence upon dopamine uptake inhibition.
    Heikkila RE; Cabbat FS; Manzino L; Duvoisin RC
    J Pharmacol Exp Ther; 1979 Oct; 211(1):189-94. PubMed ID: 573788
    [No Abstract]   [Full Text] [Related]  

  • 44. Antagonism of the acute electroencephalographic and behavioral effects of morphine in the rat by depletion of brain biogenic amines.
    Colasanti B; Khazan N
    Neuropharmacology; 1973 May; 12(5):463-9. PubMed ID: 4267733
    [No Abstract]   [Full Text] [Related]  

  • 45. Some aspects of the mechanism of action of various stimulant amphetamine analogues.
    Scheel-Krüger J
    Psychiatr Neurol Neurochir; 1972; 75(3):179-92. PubMed ID: 4402652
    [No Abstract]   [Full Text] [Related]  

  • 46. Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway.
    Oberlander C; Euvrard C; Dumont C; Boissier JR
    Eur J Pharmacol; 1979 Dec; 60(2-3):163-70. PubMed ID: 575095
    [No Abstract]   [Full Text] [Related]  

  • 47. In vivo measures of monoamines during amphetamine-induced behaviors in rats.
    Kuczenski R; Segal DS
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14 Suppl():S37-50. PubMed ID: 2097672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuronal localization of monoamines in the cerebral ganglia of the snail Helix pomatia.
    Bardessono F; Glacobini E; Stepita-Klauco M
    Brain Res; 1972 Dec; 47(2):427-37. PubMed ID: 4264629
    [No Abstract]   [Full Text] [Related]  

  • 49. Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats.
    Braestrup C
    J Pharm Pharmacol; 1977 Aug; 29(8):463-70. PubMed ID: 19594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative involvement of dopamine and noradrenaline in rate-free self-stimulation in substania nigra, lateral hypothalamus, and mesencephalic central gray.
    Liebman JM; Butcher LL
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(2):167-94. PubMed ID: 4152814
    [No Abstract]   [Full Text] [Related]  

  • 51. The relation between monoamines in brain and the anticonvulsant action of inhibition of carbonic anhydrase.
    Gray WD; Rauh CE
    J Pharmacol Exp Ther; 1971 Apr; 177(1):206-18. PubMed ID: 4254846
    [No Abstract]   [Full Text] [Related]  

  • 52. Intrahypothalamic and intrastriatal dopamine and norepinephrine injections in relation to motor hyperactivity in rats.
    Benkert O; Köhler B
    Psychopharmacologia; 1972; 24(2):318-25. PubMed ID: 4260590
    [No Abstract]   [Full Text] [Related]  

  • 53. Central serotonin involvement in the elaboration of the startle reaction in rats.
    Fechter LD
    Pharmacol Biochem Behav; 1974; 2(2):161-71. PubMed ID: 4275271
    [No Abstract]   [Full Text] [Related]  

  • 54. Release of biogenic amines from isolated nerve endings.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
    [No Abstract]   [Full Text] [Related]  

  • 55. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract]   [Full Text] [Related]  

  • 56. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS.
    Fuxe K; Hökfelt T
    Triangle; 1971; 10(3):73-84. PubMed ID: 5138525
    [No Abstract]   [Full Text] [Related]  

  • 57. Quipazine: its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour.
    Green AR; Youdim MB; Grahame-Smith DG
    Neuropharmacology; 1976 Mar; 15(3):173-9. PubMed ID: 132619
    [No Abstract]   [Full Text] [Related]  

  • 58. Brain amine levels and competitive behavior between rats in a straight runway.
    Masur J; Czeresnia S; Skitnevsky H; Carlini EA
    Pharmacol Biochem Behav; 1974; 2(1):55-62. PubMed ID: 4275179
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of palmatine on motor activity and the concentration of central monoamines and its metabolites in rats.
    Hsieh MT; Su SH; Tsai HY; Peng WH; Hsieh CC; Chen CF
    Jpn J Pharmacol; 1993 Jan; 61(1):1-5. PubMed ID: 7679763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The differential neurochemical bases of the behaviours elicited by serotonergic agents and by the combination of a monoamine oxidase inhibitor and L-DOPA.
    Deakin JF; Dashwood MR
    Neuropharmacology; 1981 Feb; 20(2):123-30. PubMed ID: 6451815
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.